Your browser doesn't support javascript.
loading
Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance.
Gouliarmou, Varvara; Lostia, Alfonso Maria; Coecke, Sandra; Bernasconi, Camilla; Bessems, Jos; Dorne, Jean Lou; Ferguson, Stephen; Testai, Emanuela; Remy, Ursula Gundert; Brian Houston, J; Monshouwer, Mario; Nong, Andy; Pelkonen, Olavi; Morath, Siegfried; Wetmore, Barbara A; Worth, Andrew; Zanelli, Ugo; Zorzoli, Maria Chiara; Whelan, Maurice.
Afiliación
  • Gouliarmou V; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy.
  • Lostia AM; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy.
  • Coecke S; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy. Electronic address: sandra.coecke@ec.europa.eu.
  • Bernasconi C; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy.
  • Bessems J; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy.
  • Dorne JL; European Food Safety Authority, Via Carlo Magno, 1A, 43126 Parma, PR, Italy.
  • Ferguson S; US National Toxicology Program, National Institute of Environmental Health Sciences, Durham, NC 27709, USA.
  • Testai E; Istituto Superiore di Sanità, Environment & Health Dept., Viale Regina Elena 299, 00161 Rome, Italy.
  • Remy UG; Institute for Clinical Pharmacology and Toxicology, Charité, Universitätsmedizin Berlin, Charitéplatz 1, D-110117 Berlin, Germany.
  • Brian Houston J; Manchester Pharmacy School, University of Manchester, Manchester M13 9PT, UK.
  • Monshouwer M; Janssen Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Nong A; Computational Toxicology Laboratory, Exposure and Biomonitoring Division, Health Canada - Environmental Health Science and Research Bureau, 50 Colombine Dwy, Environmental Health Centre, Tunney's Pasture AL:0800C, Ottawa, ON K1A 0K9, Canada.
  • Pelkonen O; Research Unit of Biomedicine/Pharmacology and Toxicology, Faculty of Medicine, Aapistie 5 B, FIN-90014, University of Oulu, Finland.
  • Morath S; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy.
  • Wetmore BA; U.S. EPA, Office of Research and Development, National Exposure Research Laboratory, 109 T.W. Alexander Drive, MD E243-04, Research Triangle Park, NC 27711, USA.
  • Worth A; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy.
  • Zanelli U; Discovery DMPK, Merck KGaA Darmstadt, Germany.
  • Zorzoli MC; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy.
  • Whelan M; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy.
Toxicol In Vitro ; 53: 233-244, 2018 Dec.
Article en En | MEDLINE | ID: mdl-30099088
ABSTRACT
Hepatic metabolic clearance is one of the most important factors driving the overall kinetics of chemicals including substances used in various product categories such as pesticides, biocides, pharmaceuticals, and cosmetics. A large number of in vitro systems from purified isozymes and subcellular organelles to hepatocytes in simple cultures and in complex scaffold setups are available for measuring hepatic metabolic clearance for different applications. However, there is currently no approach for systematically characterising and comparing these in vitro methods in terms of their design, applicability and performance. To address this, existing knowledge in the field of in vitro human hepatic metabolic clearance methods was gathered and analysed in order to establish a framework to systematically characterise methods based on a set of relevant components. An analogous framework would be also applicable for non-human in vitro systems. The components are associated with the biological test systems used (e.g. subcellular or cells), the in vitro method (e.g. number of cells, test item solubility), related analytical techniques, data interpretation methods (based on substrate depletion/metabolite formation), and performance assessments (precision and accuracy of clearance measurements). To facilitate the regulatory acceptance of this class of methods, it is intended that the framework provide the basis of harmonisation work within the OECD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hígado Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Toxicol In Vitro Asunto de la revista: TOXICOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hígado Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Toxicol In Vitro Asunto de la revista: TOXICOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia